| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Equillium, Inc. (EQ) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 1 sell. EQ is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.75M | $4.04M | - | |
| Pres | 1.15M | $2.66M | - | |
| Dir | 20.0K | $46.2K | - | |
| Dir | 20.0K | $46.2K | - | |
| Dir | 20.0K | $46.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2019 | Keyes Jason A72 | Chief Financial Officer | Sell | 5,000 | $3.99 | $19,941.00 | -3.4% |